Zevra Therapeutics (ZVRA) Payables (2014 - 2026)
Zevra Therapeutics' Payables came in at $13.96 million for Q2 2026, down 11.9% from $15.84 million a year earlier but up 19.5% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Payables was $11.6 million, down 54.4% from FY2024.
- Payables carries a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
- Going back by year, Payables was $25.46 million in FY2024 (-10.4%), $28.4 million in FY2023 (+360.4%), $6.17 million in FY2022 (+103.1%) and $3.04 million in FY2021 (-54.3%).
- The five-year range for quarterly Payables is $2.09 million (Q3 2021) to $28.4 million (Q4 2023).
- Year-over-year, Payables has declined for seven consecutive quarters, with an average decline of 15.4% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q4 2023 (growth of 360.4%), and the weakest in Q3 2021 (a decline of 97.0%).
- Business Quant data shows ZVRA's Payables at $11.69 million (Q1 2026), $11.6 million (Q4 2025) and $11.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,155.80 Bn | 1,124.39 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 630.65 Bn | 549.18 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 502.74 Bn | 475.85 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 375.34 Bn | 329.72 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 301.36 Bn | 265.35 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 265.02 Bn | 238.70 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 239.16 Bn | 194.55 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 192.63 Bn | 166.82 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.82 Bn | 118.47 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Zevra Therapeutics | 619.07 Mn | -193.64 Mn | 38.18 Mn | 13.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.96 Mn |
| Mar 31, 2026 | 11.69 Mn |
| Dec 31, 2025 | 11.60 Mn |
| Sep 30, 2025 | 11.07 Mn |
| Jun 30, 2025 | 15.84 Mn |
| Mar 31, 2025 | 17.82 Mn |
| Dec 31, 2024 | 25.46 Mn |
| Sep 30, 2024 | 24.46 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 22.79 Mn |
| Dec 31, 2023 | 28.40 Mn |
| Sep 30, 2023 | 13.08 Mn |
| Jun 30, 2023 | 10.51 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 6.17 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 2.58 Mn |
| Dec 31, 2021 | 3.04 Mn |
| Sep 30, 2021 | 2.09 Mn |
API Access
Zevra Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();